K
Kent Robinson
Researcher at Bayer
Publications - 1
Citations - 11
Kent Robinson is an academic researcher from Bayer. The author has contributed to research in topics: Population. The author has an hindex of 1, co-authored 1 publications receiving 2 citations.
Papers
More filters
Journal ArticleDOI
Cystic fibrosis improves COVID-19 survival and provides clues for treatment of SARS-CoV-2.
Edward H Abraham,Guido Guidotti,Eliezer Rapaport,David Bower,Jack Brown,Robert J. Griffin,Andrew Donnelly,Ellen D Waitzkin,Kenon Qamar,Mark A Thompson,Sukumar Ethirajan,Kent Robinson +11 more
TL;DR: Rapaport et al. as discussed by the authors showed that IV ATP can elevate the depleted ATP pools of advanced cancer patients up to levels found in CF patients with subsequent clinical, biochemical, and quality of life (QOL) improvements.